SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test
Introduction to the SCN2A Gene Test
The SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test is a cutting-edge diagnostic tool designed to identify mutations in the SCN2A gene, which is associated with severe neurological disorders. This test utilizes Next-Generation Sequencing (NGS) technology to provide comprehensive insights into genetic variations that may lead to early infantile epileptic encephalopathy (EIEE) type 11. Understanding these genetic factors is crucial for effective diagnosis and management of affected individuals.
What the Test Measures
This genetic test specifically detects mutations in the SCN2A gene. By analyzing the DNA, healthcare providers can identify alterations that may contribute to neurological disorders, particularly in infants presenting with seizures or developmental delays.
Who Should Consider This Test?
Parents or guardians of infants experiencing:
- Frequent seizures
- Developmental delays
- Unexplained neurological symptoms
Additionally, individuals with a family history of SCN2A-related disorders should consider this test for early diagnosis and intervention.
Benefits of Taking the Test
- Early diagnosis of genetic conditions associated with seizures.
- Informed treatment decisions and management plans.
- Understanding the risk of recurrence in future pregnancies.
- Access to genetic counseling and support resources.
Understanding Your Results
Results from the SCN2A Gene test will provide insights into the presence of mutations. A positive result indicates a genetic change associated with EIEE type 11, while a negative result suggests no identified mutations. It is essential to discuss results with a healthcare provider to understand their implications fully.
Test Pricing
| Test Name | Discount Price | Regular Price |
|---|---|---|
| SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test | 40,000 KSh | 56,000 KSh |
Sample Type and Turnaround Time
The test requires a sample of blood or extracted DNA, or a single drop of blood on an FTA card. Results are typically available within 3 to 4 weeks.
Pre-Test Instructions
Prior to the test, a clinical history of the patient should be provided. It is recommended to undergo a genetic counseling session to draw a pedigree chart of family members affected by the SCN2A gene.
Branches Across Kenya
DNA Labs Kenya has branches in major cities across the country, ensuring accessibility to our services. We also offer home sample collection for your convenience.
Book Your Test Today!
Don’t wait for symptoms to worsen. Take action now by booking the SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test at a discounted price of 40,000 KSh. For more information or to schedule your appointment, call or WhatsApp us at +254711564616.
